IMSC: Differentiation of isobaric residues in SPITC-derivatized tryptic peptides using MS/MS technique in a novel Curved Field Reflectron.
Posters | 2012 | ShimadzuInstrumentation
Accurate differentiation of isobaric amino acid residues such as isoleucine/leucine and α/β aspartic acid is critical for de novo peptide sequencing and comprehensive proteomic analysis. SPITC derivatization at the N-terminus introduces a fixed negative charge that enhances y-ion generation, but it traditionally lacks the resolution needed to discriminate these isomers. The development of advanced MS/MS instrumentation addresses this gap, improving sequence interpretation and protein characterization in research and QA/QC workflows.
This work evaluates a prototype MALDI-TOF/MS system equipped with novel curved field reflectron (CFR) optics and an axial spatial distribution focusing (ASDF) cell for high-resolution MS/MS. The primary goals were to demonstrate discrimination of Ile/Leu and α/β Asp in SPITC-derivatized tryptic peptides using both high-energy collision-induced dissociation (HE-CID) and post-source decay (PSD) modes, and to compare performance with a commercial AXIMA-Performance instrument.
HE-CID MS/MS experiments were conducted at 20 keV in positive ion mode using helium as the collision gas. Tryptic peptides from bovine serum albumin (BSA) and synthetic sequences derived from human α-crystallin were SPITC-derivatized, with additional guanidination and sulfonation steps for Asp isomer studies. The ASDF cell was pulsed when fragment ions entered, enhancing axial focusing before the CFR. Both HE-CID and PSD spectra were acquired on the prototype and compared with PSD data from the AXIMA-Performance.
HE-CID spectra of SPITC-derivatized peptides revealed diagnostic w-ions that distinguish Ile (w3 –45 Da) from Leu (w6 –59 Da) while preserving sequence y-ions. Comparison with AXIMA-Performance confirmed the prototype’s higher resolution and improved ion focusing. In PSD mode, α- and β-Asp isomers produced distinct y-ion intensity ratios and specific neutral losses (e.g., y7–46), enabling confident assignment. The high-resolution MS/MS also exposed an unintended deamidation during SPITC derivatization, demonstrating the system’s sensitivity to subtle mass shifts.
Continued integration of HE-CID and PSD in a single run, real-time mode switching, and coupling with high-resolution mass analyzers are expected to further refine isomer differentiation. Advances in data processing, including machine learning-driven spectrum interpretation, will streamline analysis and broaden application to complex biological samples and post-translational modification mapping.
The novel CFR-based prototype MALDI-TOF/MS with pulsed ASDF focusing successfully discriminates isobaric residues in SPITC-derivatized peptides, surpassing conventional unit-mass resolution instruments. This capability enhances de novo sequencing reliability and expands the analytical toolkit for proteomics and related fields.
(1) Cordero MM et al. Rapid Commun Mass Spectrom. 1995;9:1356–1361.
(2) Cornish TJ et al. Rapid Commun Mass Spectrom. 1993;7:1037–1040.
(3) Chen P et al. Rapid Commun Mass Spectrom. 2004;18:191–198.
(4) Yamazaki Y et al. Anal Chem. 2010;82(15):6384–6394.
MALDI, LC/MS, LC/TOF
IndustriesProteomics
ManufacturerShimadzu
Summary
Importance of the Topic
Accurate differentiation of isobaric amino acid residues such as isoleucine/leucine and α/β aspartic acid is critical for de novo peptide sequencing and comprehensive proteomic analysis. SPITC derivatization at the N-terminus introduces a fixed negative charge that enhances y-ion generation, but it traditionally lacks the resolution needed to discriminate these isomers. The development of advanced MS/MS instrumentation addresses this gap, improving sequence interpretation and protein characterization in research and QA/QC workflows.
Study Objectives and Overview
This work evaluates a prototype MALDI-TOF/MS system equipped with novel curved field reflectron (CFR) optics and an axial spatial distribution focusing (ASDF) cell for high-resolution MS/MS. The primary goals were to demonstrate discrimination of Ile/Leu and α/β Asp in SPITC-derivatized tryptic peptides using both high-energy collision-induced dissociation (HE-CID) and post-source decay (PSD) modes, and to compare performance with a commercial AXIMA-Performance instrument.
Methodology
HE-CID MS/MS experiments were conducted at 20 keV in positive ion mode using helium as the collision gas. Tryptic peptides from bovine serum albumin (BSA) and synthetic sequences derived from human α-crystallin were SPITC-derivatized, with additional guanidination and sulfonation steps for Asp isomer studies. The ASDF cell was pulsed when fragment ions entered, enhancing axial focusing before the CFR. Both HE-CID and PSD spectra were acquired on the prototype and compared with PSD data from the AXIMA-Performance.
Used Instrumentation
- Prototype MALDI-TOF/MS with curved field reflectron and pulsed ASDF cell
- AXIMA-Performance (Shimadzu Biotech/Kratos) for benchmark PSD spectra
- Helium collision cell for HE-CID at 20 keV
Key Results and Discussion
HE-CID spectra of SPITC-derivatized peptides revealed diagnostic w-ions that distinguish Ile (w3 –45 Da) from Leu (w6 –59 Da) while preserving sequence y-ions. Comparison with AXIMA-Performance confirmed the prototype’s higher resolution and improved ion focusing. In PSD mode, α- and β-Asp isomers produced distinct y-ion intensity ratios and specific neutral losses (e.g., y7–46), enabling confident assignment. The high-resolution MS/MS also exposed an unintended deamidation during SPITC derivatization, demonstrating the system’s sensitivity to subtle mass shifts.
Benefits and Practical Applications
- Enhanced de novo sequencing accuracy through reliable isomer discrimination
- Improved proteomic profiling and QA/QC in pharmaceutical and academic laboratories
- Ability to detect subtle modifications such as deamidation during sample preparation
Future Trends and Opportunities
Continued integration of HE-CID and PSD in a single run, real-time mode switching, and coupling with high-resolution mass analyzers are expected to further refine isomer differentiation. Advances in data processing, including machine learning-driven spectrum interpretation, will streamline analysis and broaden application to complex biological samples and post-translational modification mapping.
Conclusion
The novel CFR-based prototype MALDI-TOF/MS with pulsed ASDF focusing successfully discriminates isobaric residues in SPITC-derivatized peptides, surpassing conventional unit-mass resolution instruments. This capability enhances de novo sequencing reliability and expands the analytical toolkit for proteomics and related fields.
Reference
(1) Cordero MM et al. Rapid Commun Mass Spectrom. 1995;9:1356–1361.
(2) Cornish TJ et al. Rapid Commun Mass Spectrom. 1993;7:1037–1040.
(3) Chen P et al. Rapid Commun Mass Spectrom. 2004;18:191–198.
(4) Yamazaki Y et al. Anal Chem. 2010;82(15):6384–6394.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Differentiation of isobaric residues in SPITC-derivatized tryptic peptides using MS/MS technique in a Curved Field Reflectron
|Shimadzu|Posters
Differentiation of isobaric residues in SPITC-derivatized tryptic peptides using MS/MS technique in a Curved Field Reflectron. Yuzo Yamazaki, Keisuke Shima SHIMADZU CORPORATION, Kyoto, Japan Overview 3: Results 3-1: Differentiation of Ile/Leu 3-2: Differentiation of a- and bAsp(4) Specific fragment ions…
Key words
xle, xlepsd, psdspitc, spitccid, cidcooh, coohleu, leuile, iletryptic, trypticcasein, caseinpeptide, peptidederivatized, derivatizedtvld, tvldderivertization, derivertizationdmpiqafllyqepvlgpvr, dmpiqafllyqepvlgpvrsgisevr
Characterization of C-terminal and Disulfide Bond Peptides of Monoclonal Antibody (mAb) on Q-TOF Mass Spectrometer
2019|Shimadzu|Applications
Application News AD-0190 Biopharma / LCMS-9030 Characterization of C-terminal and Disulfide Bond Peptides of Monoclonal Antibody (mAb) on Q-TOF Mass Spectrometer Udi Jumhawan and Zhaoqi Zhan Application Development & Support Centre, Shimadzu (Asia Pacific), Singapore 1. Introduction In recent years,…
Key words
vyacevthqglsspvtk, vyacevthqglsspvtkterminal, terminallysine, lysinepeptide, peptideslslspg, slslspghinge, hingepeptides, peptidesnews, newseics, eicsmin, minclipped, clippeddisulfide, disulfidebevacizumab, bevacizumablocation, locationnovo
Structure Characterization and Differentiation of Biosimilar and Reference Products Using Unique Combination of Complementary Fragmentation Mechanisms
2014|Thermo Fisher Scientific|Posters
Structure Characterization and Differentiation of Biosimilar and Reference Products Using Unique Combination of Complementary Fragmentation Mechanisms Zhiqi Hao,1 Chen Li, 2 Shiaw-Lin Wu, 2,3 David M. Horn1 and Jonathan Josephs1 1 Thermo Fisher Scientific, San Jose, CA; 2BioAnalytix Inc, Cambridge,…
Key words
tnk, tnkglycosylation, glycosylationggnm, ggnmglycoforms, glycoformspeptide, peptidebiosimilar, biosimilarggn, ggnhcd, hcdtpa, tpaspectrum, spectrumsggn, sggnetd, etdnhnycr, nhnycrnycr, nycrycr
In-depth Peptide Mapping of Monoclonal Antibody (mAb) by A de novo Peptide Sequencing Method on Q-TOF Mass Spectrometer with Data-independent Acquisition
2019|Shimadzu|Applications
Application News No. AD-0217 Biopharma / LCMS-9030 (Q-TOF) In-depth Peptide Mapping of Monoclonal Antibody (mAb) by A de novo Peptide Sequencing Method on Q-TOF Mass Spectrometer with Data-independent Acquisition Yonghai Lu and Zhaoqi Zhan Application Development & Support Centre, Shimadzu…
Key words
peptide, peptidedia, dianovo, novomab, mabmapping, mappingbevacizumab, bevacizumabchain, chainsequencing, sequencingalpapiek, alpapiekpeptides, peptidestryptic, trypticnews, newsdial, dialmonoclonal, monoclonalheavy